Home/ Supplements/ Vitamin A/ Pressur-Lo

Pressur-Lo

product on market Tablet or Pill Bronson Safety: 99/100
99/100

This product looks safe

  • Niacin: 60mg is 1.7× the Tolerable Upper Intake Level (35mg)
  • 47% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains a blend of essential vitamins, including A, C, D, and B-complex, which support general immune function and metabolic processes. There is strong evidence supporting the roles of these vitamins in maintaining overall health. However, the specific evidence coverage for this formulation's combined effect is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 60mg is 1.7× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Pressur-Lo
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
Other Combinations
Product Type
47%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
2000 IU (40% DV)
Vitamin C
120 mg (200% DV)
50 IU (13% DV)
Within RDA (0.1× RDA) 608 studies (A:16, B:251)
4 mg (266% DV)
3.3× RDA — above typical dose 76 studies (A:0, B:33)
4 mg (235% DV)
3.1× RDA — above typical dose 13 studies (A:0, B:1)
60 mg (300% DV)
Exceeds UL by 1.7× (UL: 35 mg) 196 studies (A:5, B:63)
4 mg (200% DV)
3.1× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
10 mcg (167% DV)
4.2× RDA — above typical dose 139 studies (A:1, B:44)
40 mg (400% DV)
8.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
160 mg (16% DV)
120 mg (30% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
6 mg (40% DV)
Within RDA (0.5× RDA) 263 studies (A:6, B:134)
40 mcg (57% DV)
Within RDA (0.7× RDA) 173 studies (A:0, B:67)
8 mg (400% DV)
3.5× RDA — above typical dose (UL: 11 mg) 9 studies — no high-quality reviews
60 mcg (50% DV)
1.7× RDA — within safe limits 199 studies (A:1, B:55)
Potassium
110 mg (3.14% DV)
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
160 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Market median: 333.0mg (166 products) 9 studies (A:0, B:2)
Beta-sitosterol Complex
70 mg
Horsetail Leaf
60 mg
Juniper berry
60 mg
60 mg
Market median: 300.0mg (214 products) 25 studies (A:0, B:6)
Cayenne
50 mg
50 mg
Market median: 500.0mg (19 products)
50 mg
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Polygonum cuspidatum root extract
6.66 mg
Co Q-10
3.34 mg
Bronson BioAccelerators
7.66 mg

Other Ingredients

Cellulose Stearic Acid Magnesium Stearate Silica Aqueous Tablet Coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: As a dietary supplement for adults, take 2 tablets 3 times daily with meals or as directed by a healthcare professional.

Warnings & Precautions

WARNING: If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of children.

If you are currently taking a diuretic or other medication, seek the advice of your healthcare professional before taking this product.

Formulation Notes

Contains soy.

Additional Information

F1112504 EXP.11/2013

Store in a cool, dry place. Protect from light.

Made in USA

No. 904A REF 0610

NUTRITIONALLY SUPPORTS CARDIOVASCULAR FUNCTION

Metadata

Product Details

UPC / SKU7 16563 90401 2
DSLD Entry Date2012-04-26
Product TypeOther Combinations
FormTablet or Pill
BrandBronson
DSLD ID8231
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.